About this trial
The objective of this study is to simultaneously acquire sleep and breathing data using the under-mattress Sleeptracker (The Sleeptracker-AI Monitor (Fullpower Technologies, California, USA) during routine PSGs in patients who attend the Woolcock Institute for undergoing investigation for possible obstructive sleep apnoea (OSA).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 20-90 years old at time of assessment.
Attending the Woolcock Institute for an overnight sleep study for investigation of sleep apnoea.
Able to give informed consent.
Fluent in English.
Disqualifiers
Unable to understand study procedure.
Unable to sign informed consent form.
Trial population
Patients referred to the Woolcock Institute for a diagnostic sleep study for possible sleep apnea.
Trial design
Cohort
Retrospective
Treatments tested in this trial
Sleeptracker-AI
DeviceThe Sleeptracker-AI Monitor (Fullpower Technologies, California, USA) is a commercially available, unobtrusive, and non-wearable home sleep monitoring device. It is either pre-installed in a mattress or can be purchased separately by consumers where it is placed under the mattress. The device uses piezo-electric sensors that register the forces exerted through the mattress by features such as the subject's motion, respiration, heartbeats, and snoring vibrations.
Treatment groups
Trial outcomes
Primary outcomes
Apnea Hypopnea Index
AHI (events per hour of sleep)
Secondary outcomes
Total Sleep Time
Total Sleep Time (minutes)
NREM Sleep Time
Non-REM sleep time (minutes)
REM Sleep Time
REM sleep time (minutes)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Woolcock Institute of Medical Research
Lead sponsor
Fullpower Technologies, Inc.
Collaborator